Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME
Estimated value
£120k
Awarded value
£120k
Suppliers
1
Lots
1
Published
11 May 2023
Description
The "Pharmacogenetics as a Service" component of the PROGRESS Programme, aims to develop a digital solution which allows the persistence and messaging of pharmacogenetic data. This will be performed in the context of an initial pilot as part of the wider PROGRESS Programme, but any solution should have the potential to scale across the NHS.
Scope
- Reference
- MFT23-0008
- Total value
- £119,880 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 16 Apr 2023 to 16 Dec 2024
- CPV classifications
- 48000000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 12 Apr 2023, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£120k
Award date
11 Apr 2023
Contract start
16 Apr 2023
Contract end
16 Dec 2024
Awarded suppliers· 1 supplier
Awarded 11 Apr 2023 · Contract period 16 Apr 2023 — 16 Dec 2024
Other contracts from Manchester University NHS Foundation Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to CLINICAL ARCHITECTURE LIMITED· 2
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| G Cloud 15 | contract | — | 24 Jul 2026 |
| Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME | contract | £268k | 24 Dec 2024 |